The effects of coenzyme Q10 supplementation on cardiometabolic markers in overweight type 2 diabetic patients with stable myocardial infarction: A randomized, double-blind, placebo-controlled trial

BACKGROUND: Limited data are present that have assessed the effects of coenzyme Q10 (CoQ10) intake on cardiometabolic markers in type 2 diabetic patients with coronary heart disease (CHD). This study was done to determine the effects of CoQ10 administration on cardiometabolic markers in overweight d...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirhashemi, Seyyed Mehdi, Najafi, Vajiheh, Raygan, Fariba, Asemi, Zatollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266131/
https://www.ncbi.nlm.nih.gov/pubmed/28149310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266131/
https://www.ncbi.nlm.nih.gov/pubmed/28149310

Ejemplares similares